Results 91 to 100 of about 10,485 (198)

Profile of teriparatide in the management of postmenopausal osteoporosis

, 2010
Andrea Sikon1, Pelin Batur21Cleveland Clinic Lerner COM, Cleveland Clinic, Cleveland, OH, USA; 2Cleveland Clinic Lerner COM, Cleveland Clinic Independence, Independence, OH, USAAbstract: One out of every 2 women within postmenopause are at risk of ...
Andrea Sikon, Pelin Batur
core  

Safety and effectiveness of daily teriparatide in a prospective observational study in patients with osteoporosis at high risk of fracture in Japan: final report

, 2016
Atsushi Nishikawa,1 Takehiro Ishida,2 Masanori Taketsuna,3 Fumito Yoshiki,4 Hiroyuki Enomoto4 1Global Patient Safety Japan, Quality and Patient Safety, 2Clinical Development Operations and Innovations, Medicine Development Unit Japan, 3Asia Pacific ...
Enomoto H, Nishikawa A, Yoshiki F, Ishida T, Taketsuna M   +4 more
core  

Denosumab, teriparatide and bisphosphonates for glucocorticoid-induced osteoporosis: a Bayesian network meta-analysis

Frontiers in Pharmacology
Background: Several medications have been used for glucocorticoids-induced osteoporosis (GIO). However, the best therapeutic option for GIO is still controversial.
Liang Dong, Lianghai Jiang, Zhengwei Xu, Xiaobo Zhang   +3 more
doaj   +1 more source

Teriparatide and orthopedic surgery

, 2007
Teriparatide has an anabolic effect on bone tissue, leading to an increase in bone strength with a reduction in the risk of fragility fractures in osteoporotic women.
GIMIGLIANO, Francesca, IOLASCON, Giovanni, Resmini G.   +2 more
core  

Efficay and safety of teriparatide treatment

, 2013
Teriparatide is the only available anabolic drug for treatment of post-menopausal and glucocorticoid-induced osteoporosis. Recent studies demonstrated the efficacy of teriparatide, but few data are available concerning treatment adherence and tolerance ...
ZATELLI, Maria Chiara, AMBROSIO, Maria Rosaria, LUPO, Sabrina, R. La Corte, T. Tommasin, S. Bianchi, FRANCESCHETTI, Paola, BONDANELLI, Marta, DEGLI UBERTI, Ettore   +8 more
core  

Hypercalcemic encephalopathy due to milk alkali syndrome and injection teriparatide

, 2012
An 82-year-old male, a known case of severe osteoporosis with vertebral fracture and prostatic carcinoma, was treated with gonadotropin releasing hormone analogue, calcium carbonate, cholecalciferol sachet and injection teriparatide.
Aditi Pandit, Abhay Gundgurthi, M K Garg, Karninder S Brar, Sandeep Kharb   +4 more
core   +1 more source

Teriparatide mitigates oxidative stress following spinal cord injury and enhances neurological recovery via the Nrf2/HO-1 signaling pathway

Frontiers in Pharmacology
IntroductionSpinal Cord Injury (SCI) represents a devastating form of central nervous system trauma, where oxidative stress plays a critical role in the ensuing pathology. Targeting oxidative stress presents a viable therapeutic avenue.
Xiong Moliang, Ai Gangtong, Feng Yun, Luo Caiguang, Deng Liang, Guo Jia, Xiao Qiang   +6 more
doaj   +1 more source

Weekly Injection of Teriparatide for Bone Ingrowth after Cementless Total Knee Arthroplasty

Journal of Orthopaedic Surgery, 2016
Purpose. To compare bone mineral density (BMD) in patients with or without weekly injection of teriparatide to promote bone ingrowth after cementless total knee arthroplasty (TKA). Methods.
Takao Kaneko, Takahiro Otani, Norihiko Kono, Yuta Mochizuki, Takeo Mori, Nobuhito Nango, Hiroyasu Ikegami, Yoshiro Musha   +7 more
doaj   +1 more source

Teriparatide as treatment of the Medication Related Osteonecrosis of the Jaws (MRONJ): a Scoping Review: TREATMENT OF MRONJ USING TERIPARATIDE

Introduction: Medication-related osteonecrosis of the jaw (MRONJ) is a serious complication affecting patients undergoing therapy with bisphosphonates and other antiresorptive agents.
Bustos Ponce, Alexis Paolo, Dethlefs Canto, Jessika, Hurtado Almonacid, Montserrat, Villavicencio Duarte, Javier, Baeza Vallejos, Solange, Pérez Escobari, Javiera   +5 more
core   +1 more source

The cost-effectiveness of therapy with teriparatide and alendronate in women with severe osteoporosis

, 2013
Background Teriparatide is a promising new agent for the treatment of osteoporosis. Methods The objective of this study was to evaluate the cost-effectiveness of teriparatide-based strategies compared with alendronate sodium for the first-line ...
Karpf, David B., Nayak, Smita, Garber, Alan, Liu, Hau, Michaud, Kaleb, Owens, Douglas K.   +5 more
core   +1 more source